Pharmaniaga’s growth plans


The group’s focus in the near term would be South-East Asia, says Zulkarnain.

THINGS are looking up for Pharmaniaga Bhd, at least for the next five to 10 years. The homegrown pharmaceutical company has ambitious plans not only to strengthen its foothold in existing markets but also to foray into new international markets.

For the last two decades, the group had established a strong market presence in Indonesia for drug manufacturing and logistics and distribution (L&D). Now, Pharmaniaga has set its sights on markets like the Middle East, Africa and the United States.

Celebrate Merdeka with 50% Off!
T&C applies.

Monthly Plan

RM13.90/month
RM6.95 only

Billed as RM6.95 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM6.17/month

Billed as RM78 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

US consumer prices rise moderately in August
IHH unit to establish RM15bil sukuk wakalah programmes
PUC to dispose of associate company for RM11.67mil
Hong Kong stock tied to pop star Jay Chou suddenly plunges 72%
Mikro MSC to buy TES Productions for RM30mil, diversify into signage business
Ringgit rises against US dollar, approaches immediate support level of RM4.3259
BAuto expects stiff competition from China-based auto companies
Widad to acquire Nilai industrial lands; purchase price to be determined
Asean digital economy framework set to be a gamechanger
Genting Malaysia’s units price US$525mil notes, secure ratings

Others Also Read